Articles

Primer on boards of directors

Do you know what the board is doing? Does the board know what you are doing?
Written byPeter Kissinger
| 6 min read

The decade just ended has been particularly unsettling withrespect to underperforming company boards. Why has this happened? I'm not sure,but let me start with the definition of a business and the roles of variousstakeholders.

Businesses and their shareholders are rewarded for servingcustomers at a selling price the customer values above the cost the businessincurred. Accountability for achieving this is fairly simple when the businessmanagers are owners. When the owners are remote, away from operations and oftenrather passive, it quickly becomes more complicated.

Theoretically, a board of directors represents the fiduciaryinterests of the owner shareholders, holds management accountable, considerssuccession and provides wisdom for matters ranging from compensation to mergersand, of course, strategy. But like for a Democratic legislature, the shareholdervoters are rarely perfectly represented. This is perceived more when things gobadly, but as we have seen, things may only appear to be going well.

Shareholder dissent of the "tea party" sort is not uncommon.The chance for input is rare and the opportunity to vote is rarer still. Infact, companies put up defenses to shareholder action that are costly toovercome. While these defenses seem appropriate to thwart unfriendly advances,they are just as inhibitory to long-term owners.

Lately, boards have been put under additional stress fromrules that add liability and cost, but contribute nothing to good governance,which requires strong values, not rules. In the life science arena, there canbe additional ethical challenges with respect to clinical trials andcommunicating adverse events.

What do they know and when do they know it?

What is the source of all this angst? For one, board membersoften don't have time to serve on boards. Likewise, busy executives don't havetime to fully engage and inform their own board. Quarterly board meetings comeup quickly in the face of day-to-day operating challenges. This is especiallytrue for small public companies without staff to assist with boardrelations.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Top view of a laboratory researcher wearing green gloves and using a pipette to transfer liquid at a bench surrounded by other laboratory equipment.
​​​​​Repetitive pipetting can strain the hands, wrists, shoulders, and neck, making ergonomics an important part of efficient liquid handling.
A gloved hand holds two glass microscope slides containing pink-stained tissue sections in a laboratory setting.
See how advanced slide-based imaging connects tissue architecture with cellular detail across fluorescent and histological samples.
Illustration of brightly coloured pink and purple cells floating against a blue background.
Explore how high-dimensional flow cytometry can expand immune profiling and support immunotoxicology assessment during preclinical drug development.